Patient Leaflet Updated 21-Apr-2026 | Novo Nordisk Limited
Wegovy 7.2 mg solution for injection in pre-filled pen (semaglutide)
wegovy® 7.2 mg solution for injection in pre-filled pen
semaglutide
▼This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects.
1. What wegovy® is and what it is used for
2. What you need to know before you use wegovy®
3. How to use wegovy®
4. Possible side effects
5. How to store wegovy®
6. Contents of the pack and other information
wegovy® is a medicine for weight loss and weight maintenance that contains the active substance semaglutide. It is similar to a natural hormone called glucagon-like peptide-1 (GLP-1) that is released from the intestine after a meal. wegovy® works by acting on receptors in the brain that control your appetite, causing you to feel fuller and less hungry and experience less craving for food. This will help you eat less food and reduce your body weight. wegovy® should be used with a reduced calorie meal plan and increased physical activity.
Weight management
wegovy® is used for weight loss and weight maintenance in addition to diet and physical activity in adults, who have:
BMI (Body Mass Index) is a measure of your weight in relation to your height.
Do not use wegovy® if you are allergic to semaglutide or any of the other ingredients of this medicine (listed in section 6).
Talk to your doctor, pharmacist or nurse before using wegovy® or during treatment if you have:
If you know that you are due to have surgery where you will be under anaesthesia (sleeping), please tell your doctor that you are taking wegovy®.
The safety and efficacy of wegovy® 7.2 mg has not been studied in children (below 12 years of age) or adolescents (above 12 years of age).
Tell your doctor, pharmacist or nurse if you are using, have recently used or might use any other medicines.
This medicine should not be used during pregnancy, as it is not known if it may affect your unborn child. Therefore, it is recommended to use contraception while using this medicine. If you wish to become pregnant, you should stop using this medicine at least two months in advance. If you become or are pregnant, think you may be pregnant or are planning to have a baby when using this medicine, talk to your doctor straight away, as your treatment will need to be stopped.
You should not use this medicine if you are breast-feeding, as it is unknown if it passes into breast milk.
wegovy® is unlikely to affect your ability to drive and use machines. Some patients may feel dizzy when taking wegovy® mainly during the first 3 months of treatment (see section 4). If you feel dizzy you should not drive or operate machines until you feel better. If you need any further information, talk to your doctor, pharmacist or nurse.
For diabetics using this medicine in combination with a sulfonylurea or insulin, low blood sugar (hypoglycaemia) may occur which may reduce your ability to concentrate. Do not drive or use machines if you get any signs of low blood sugar. See section 2, ‘Warnings and precautions’ for information on increased risk of low blood sugar and section 4 for the warning signs of low blood sugar. Talk to your doctor for further information.
This medicine contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially ‘sodium-free’.
Always use this medicine exactly as your doctor has told you. Check with your doctor, pharmacist or nurse if you are not sure.
Adults
For weight management
Your treatment will start at a low dose which will be gradually increased over 16 weeks of treatment as follows:
For weight management in patients with obesity
Usually, you will be told to follow the table below.
For weight management
Dose escalation Weekly dose
Week 1–4 0.25 mg
Week 5–8 0.5 mg
Week 9–12 1 mg
Week 13–16 1.7 mg
From week 17 2.4 mg
From week 21 – for adult patients with obesity, if needed 7.2 mg
Your doctor will assess your treatment on a regular basis.
wegovy® is given as an injection under the skin (subcutaneous injection). Do not inject it into a vein or muscle.
Detailed instructions for use are on the other side of this leaflet.
Tell your doctor if you have diabetes. Your doctor may adjust the dose of your diabetes medicines to prevent you from getting low blood sugar.
If necessary, you can change the day of your weekly injection of this medicine as long as it has been at least 3 days since your last injection. After selecting a new dosing day, continue with once a week dosing.
Talk to your doctor straight away. You may get side effects such as feeling sick (nausea).
If you forgot to inject a dose and:
Do not stop using this medicine without talking to your doctor.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Not known (frequency cannot be estimated from the available data)
Very common: may affect more than 1 in 10 people
These usually go away over time.
Common: may affect up to 1 in 10 people
The warning signs of low blood sugar may come on suddenly. They can include: cold sweat, cool pale skin, headache, fast heartbeat, feeling sick (nausea) or very hungry, changes in vision, feeling sleepy or weak, feeling nervous, anxious or confused, difficulty concentrating or shaking.
Your doctor will tell you how to treat low blood sugar and what to do if you notice these warning signs.
Low blood sugar is more likely to happen if you also take a sulfonylurea or insulin. Your doctor may reduce your dose of these medicines before you start using this medicine.
Uncommon: may affect up to 1 in 100 people
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the pen label and carton after ‘EXP’. The expiry date refers to the last day of that month.
Do not freeze wegovy® and do not use it if it has been frozen.
Always store the pen in the original carton in order to protect from light.
Store in a refrigerator (2°C to 8°C). Keep away from the cooling element.
wegovy® may be stored unrefrigerated for up to 28 days at a temperature not above 30°C.
Discard the pen if it has been exposed to light or temperatures above 30°C, has been out of the refrigerator for more than 28 days, or has been frozen.
Do not use this medicine if you notice that the solution is not clear and colourless.
The pen is for single use and contains one dose only. Discard pen after use.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
wegovy® 7.2 mg solution for injection
Each pre-filled pen contains 7.2 mg of semaglutide in 0.75 mL (9.6 mg/mL)
wegovy® is a clear and colourless solution for injection in a pre-filled disposable pen.
Each pen contains one dose only.
Pack size of 4 pre-filled pens
This leaflet was last revised in: 03/2026
wegovy® is a trademark owned by Novo Nordisk A/S, Denmark
© 2026
Novo Nordisk A/S
The package contains one package leaflet and four wegovy® pre-filled pens.
This part of the package leaflet instructs on how to use the pen. For further information regarding your medicine please refer to the other side of this package leaflet.
Each pen is only to be used once.
It comes with:
When injecting the dose, a yellow bar will appear in the pen window. Do not lift the pen before the yellow bar has stopped moving. If you do, the automatic dosing will continue, but you may not receive your full dose.
The needle cover will lock when the pen is removed from your skin. You cannot pause the injection and restart it later.
People who are blind or have vision problems should not use wegovy® pen without help from a person trained to use wegovy®.
Always follow these user instructions and any directions given by your doctor or nurse.
1. Prepare for your injection.
Check your wegovy pen and be careful not to use your pen if:
1. it has expired
2. it appears to have been used or damaged, e.g. if it has been dropped or stored incorrectly
3. the medicine looks cloudy.
Choose your injection site
Choose an injection site in one of the body areas marked below. You can choose your upper arms, upper legs or stomach (keep a 5 cm distance from your belly button).
You may inject in the same body area each week, but make sure it is not in the same spot as used the last time.
2. Remove pen cap.
Pull the pen cap straight off your pen.
3. Inject wegovy®
Press the pen firmly against your skin until the yellow bar has stopped moving.
If the yellow bar does not start moving, press the pen more firmly against your skin.
The injection takes about 5-10 seconds
Click 1
The injection starts.
Click 2
Keep holding for a few seconds until yellow bar stops moving.
Yellow bar has stopped moving. The injection is complete. Lift the pen slowly and safely dispose of the pen.
For information regarding your medicine please refer to the other side of this package leaflet.
For information regarding storage see section 5 on the other side of this package leaflet.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
3 City Place, Beehive Ring Road, Gatwick, West Sussex, RH6 0PA
+44 (0)1293 613535
+44 (0)800 023 2573
http://www.novonordisk.co.uk
+44 (0)1293 613555
+44 (0)800 023 2573